Sjogren’s Syndrome CD19+ B Cells
About: Sjogren’s Syndrome CD19 B Cells are isolated from peripheral blood of IRB-consented donors. Designed for research on exocrine gland autoimmunity, B cell hyperactivity, and disease-specific biomarker discovery.
High-Quality Sjogren’s Syndrome CD19 B Cells for Immunology and Autoimmune Research
Sjogren’s Syndrome B Cells are purified from peripheral blood of IRB-consented adult donors diagnosed with Sjogren’s Syndrome. These disease-relevant B lymphocytes support in-depth studies of immune dysregulation, autoantibody production, and chronic inflammation associated with Sjogren’s Syndrome. Cryopreserved for optimal viability, these cells are ideal for translational research and therapeutic discovery.
Product Features
- Research Use Only (RUO), CD19+ B cells
- Isolated from Sjogren’s Syndrome donors with confirmed clinical diagnosis
- High purity and viability
- Cryopreserved using CryoStor® CS10 media
- Processed within 24 hours of collection
- IRB-approved protocols and HIPAA-compliant handling
De-identified Donor Data
- Confirmed diagnosis of Sjogren’s Syndrome
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and clinical history available
Applications
- Disease-specific B cell profiling and immune phenotyping
- Autoantibody production and BCR signaling studies
- Autoimmune and chronic inflammatory disease modeling
- Biomarker discovery and therapeutic target validation
Compliance and Quality Assurance
- IRB-approved collections with 21 CFR Part 11–compliant e-consent
- Standardized processing and cryopreservation protocols
- HIPAA-compliant donor data protection
Ordering & Customization
Sjogren’s Syndrome CD19 B Cells are available in standard or custom aliquot sizes. For international shipping, documentation, or regulatory support, please contact learnmore@sanguinebio.com.
Protocols & Documentation
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
CD19+ B Cells
Frequently Asked Questions
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – All three cell types are available.
Ask a Question
Need a custom CD19+ B Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.